Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative ibuprofen or Netonal for post-endodontic pain in irreversible pulpitis
IRCT20230313057710N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ibuprofen and Placebo-COD Research Private Ltd in irreversible pulpitis (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Pain, Immediate post-treatment pain and 4 more. Started Jul 2019; status: completed.
02
Drugs
ibuprofenPlacebo-COD Research Private Ltd
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on IRCT20230313057710N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230313057710N2.